Expertise in
2
conditions
Expertise in
2
conditions
Office
8701 Watertown Plank Rd, 
Milwaukee, WI 

Overview

Meghen Browning is a Hematologist and an Oncologist practicing medicine in Milwaukee, Wisconsin.

Dr. Browning is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Desmoid Tumor, Desmoplastic Small Round Cell Tumor, Adult Soft Tissue Sarcoma, and Osteosarcoma.

She is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 19 clinical trials.

Specialties

Hematology
Oncology

Licenses

Pediatric Hematology-Oncology in WI

Languages Spoken

English
German

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID

Locations

Office
8701 Watertown Plank Rd, Milwaukee, WI 53226

Additional Areas of Focus

Dr. Browning has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


19 Clinical Trials

Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma (NBL)
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
View 7 Less Clinical Trials
Similar Doctors
Expertise in
4
conditions
Hematology | Oncology
Expertise in
4
conditions
Hematology | Oncology
Referral may be required

Childrens Hospital Of Wisconsin Inc

8915 W Connell Ave, 
Milwaukee, WI 
 (0.1 miles away)
Languages Spoken:
English

Robert Montgomery is a Hematologist and an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Montgomery is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Von Willebrand Disease (VWD), Blood Clots, Hemophilia A, and Bernard-Soulier Syndrome.

Expertise in
31
conditions
Hematology | Oncology
Expertise in
31
conditions
Hematology | Oncology
Referral may be required

Clinical Cancer Center - Froedtert Hospital

8800 W. Doyne Ave., 
Milwaukee, WI 
 (0.3 miles away)
Languages Spoken:
English, Gujarati 
Accepting New Patients
Offers Telehealth

Nirav Shah, MD, MSHP, is an associate professor of medicine (hematology and oncology) at the Medical College of Wisconsin, specializing in lymphoma, CAR-T cell therapy, and stem cell transplant at Froedtert Hospital. He graduated with honors and Alpha Omega Alpha Honor Society membership from the University of Illinois at Chicago College of Medicine in 2008. He then completed his internal medicine residency at Massachusetts General Hospital in Boston, Massachusetts in 2011. Post-residency, he took a position at Northwestern Memorial Hospital in Hospitalist medicine before proceeding to the University of Pennsylvania where he completed both hematology/oncology fellowship and a Master’s degree in Health Policy research in 2015. His research focus is in the area of novel agents and cell therapy development for hematological malignancies. He is currently director of the Bone Marrow Transplant and Cellular Therapy Program at the Medical College of Wisconsin. Dr. Shah is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Shah is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Shah is currently accepting new patients.

Expertise in
30
conditions
Hematology | Oncology
Expertise in
30
conditions
Hematology | Oncology
Referral may be required

Froedtert Clinical Cancer Center

8800 W Doyne Ave, 
Milwaukee, WI 
 (0.3 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

John Charlson is a Hematologist and an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Charlson is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Synovial Sarcoma, and Undifferentiated Pleomorphic Sarcoma. Dr. Charlson is board certified in Medical Oncology. Dr. Charlson is currently accepting new patients.

Frequently Asked Questions about Dr. Meghen B. Browning

How do I make an appointment with Dr. Meghen B. Browning?

You can book an appointment with Dr. Meghen B. Browning by calling their office at 414-266-2420. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Meghen B. Browning a top-rated expert for Desmoid Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Meghen B. Browning is classified as an Advanced expert for Desmoid Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Meghen B. Browning specialize in?

While Dr. Meghen B. Browning is a Hematology, they have specific expertise in Desmoid Tumor, Desmoplastic Small Round Cell Tumor, and Adult Soft Tissue Sarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Meghen B. Browning participate in research or clinical trials?

Yes. Dr. Meghen B. Browning has published 9 articles and abstracts on conditions like Desmoid Tumor. You can view a list of Dr. Meghen B. Browning's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Meghen B. Browning accept my insurance?

Dr. Meghen B. Browning accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 414-266-2420 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Browning's expertise for a condition
ConditionClose
      View All 13 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile